Diabetes Care 27:1335-1342, 2004
27 For those patients using GLP-1 agonist drugs for weight loss, various side effects have been reported including nausea, vomiting, abdominal pain, diarrhea, constipation, gastroenteritis, and certain incidents of pancreatitis and bowel obstruction
5 mg/mL tirzepatide conversion chart: At 5 mg/mL, a standard 1 mL syringe maxes out at only 5 mg per injection
Learn more about Propanediol Disodium EDTA is a chelating agent
FAQs: managing your GLP-1 journey How to reduce GLP-1 side effects quickly
Another recent randomized trial examined a lower dose of semaglutide in non-treatment-seeking adults with alcohol use disorder and reported reduced alcohol intake during a laboratory self-administration task